ELN484228 is a blocker of α-synuclein which is a key protein in Parkinson's disease.
[1]. Tóth G, et al. Targeting the intrinsically disordered structural ensemble of α-synuclein by small molecules as a potential therapeutic strategy for Parkinson's disease. PLoS One. 2014 Feb 14;9(2):e87133.
















